Neuroimaging
Neuroimaging
Guidelines
Headache
With the development of more sophisticated neuroimaging technology,
practitioners must become familiar with the appropriate selection
of diagnostic imaging procedures for patients presenting with headache.
Prior to the development of CT scan and MRI, electroencephalogram
(EEG) was the modality used to evaluate patients with headache (1).
With the advent of superior imaging procedures, this technique is
no longer recommended. American Academy of Neurology guidelines
now state that (2):
The electroencephalogram (EEG) is not useful in
the routine evaluation of patients with headache. This does not
exclude the use of EEG to evaluate headache patients with associated
symptoms, suggesting a seizure disorder such as atypical migrainous
aura or episodic loss of consciousness. Assuming head imaging capabilities
are readily available, EEG is not recommended to exclude a structural
cause of headache.
CT
Scan
CT scans pass x-ray beams through the head allowing a computer
to create a cross-sectional representation. Contrast highlights
blood vessels, the pituitary gland, choroid plexus and dura. When
the blood-brain barrier (BBB) is compromised, contrast will also
highlight lesions causing defects in the BBB, such as infectious
lesions, tumors and infarctions.
The CT scan is superior to the MRI in the evaluation of acute
parenchymal, subdural and subarachnoid bleeds. For subacute and
chronic bleeds, however, the MRI is the study of choice.Over time,
the probability of recognizing an aneurysmal hemorrhage on CT
scan declines (1) (Table I):
Table I
|
Percentage of Subarachnoid Hemorrhages
Evident on CT Scan of the Brain Over Time |
| DAYS
POST EVENT |
POSITIVE
FINDINGS |
Day 0 |
95% |
| Day 3 |
74% |
| Day 7 |
50% |
| Day 14 |
30% |
| Day 21 |
almost 0% |
Non-contrast CT scans also play an important role in the evaluation
of patients with acute head trauma by delineating the bony calvarium,
including the osseous skull base and temporal bones.
Disadvantages of using a CT scan include exposure to radiation
and potential allergic reactions from contrast, such as anaphylaxis.
MRI
Magnetic resonance imaging is an excellent imaging modality to
evaluate most intracranial processes. The MRI measures the energy
produced when protons in biologic tissue energized by a magnetic
field move from the energized to the relaxed state.
Table II
| Indications for MRI |
| Subacute
and chronic hemorrhages |
| Cerebral infarction |
| Primary
and metastatic brain tumors |
| Intracranial abscess |
| Multiple
sclerosis and other demyelinating diseases |
| New onset or refractory
seizures |
| Vasculitides |
MRI is superior to CT scan in the evaluation of most intracranial
processes that may be associated with headache (Table II). MRI
with gadolinium is useful when looking for primary and metastatic
brain tumors, brain abscess and other infectious lesions and demyelinating
diseases and cranial nerve and meningeal abnormalities, because
gadolinium-based contrast will highlight areas where the BBB is
compromised.
MRI is also valuable in the evaluation of vascular lesions of
the brain but ideally in conjunction with an MRA or cerebral angiogram.
One disadvantage of MRI is the requirement that the patient not
move at all during the procedure. Also, patients who are morbidly
obese, claustrophobic or contain metal clips or fragments may
not be candidates for MRI.
MRA
Magnetic resonance angiography picks up fast-moving blood and,
by suppressing background signals, permits visualization of a
vascular flow map. It has less resolution than conventional angiography,
however, and may not pick up small lesions such as aneurysms <
3 mm in size. It also cannot detect slow-moving blood well and
may miss occlusive or near-occlusive cerebrovascular disease.
Nevertheless, combined with MRI, MRA has many indications (Table
III).
Table III
| Indications for MRI / MRA |
| Vertebrobasilar
insufficiency |
| Carotid or vertebral dissection |
| AVM detection |
| History of familial aneurysms |
Cerebral Angiogram
Cerebral angiography involves threading a catheter, usually through
the femoral artery, and then injecting contrast material into
a blood vessel.
It may be useful in imaging small vessel disease such as
cerebral vasculitis, small aneurysms, AVMs and cerebrovascular
occlusive disease. It is generally the modality of choice when
therapy is planned and is the modality through which intravascular
therapeutic procedures are performed.
Cerebral angiography is generally considered the gold standard
for evaluating cerebral aneurysms following a subarachnoid hemorrhage.
The major risk of cerebral angiography is the 4% chance of stroke
and the potential neurotoxic effects of the hyperosmolar contrast
material (3).
Positron Emission Tomography and Single
Photon Emission Tomography
PET and SPECT scans measure brain perfusion or metabolism by
detecting the uptake of biologically active radioligand tracers
as they participate in biological processes (4).
These studies differ in terms of equipment and sensitivity. Although
PET scans are often more sensitive than SPECT studies, they require
more expensive technology and close proximity to the radionucleotide
source (due to the short half-life of the radioisotopes).
The indications for the use of PET or SPECT in the study of brain
function continue to expand. Several of the widely accepted indications
are listed below (Table IV).
Table IV
| Indications for PET/SPECT Scans |
| Differentiate
active brain tumor from radiation-induced necrosis |
| Pre-operative evaluation
of intractable seizures/epilepsy |
| Differentiate
CNS lymphoma from toxoplasmosis in AIDS patients |
Conclusion
In conclusion, chest radiography is indicated only when there
is a clinical suspicion of chest disease based on findings on
a prior medical history and physical examination.
We would like to acknowledge the editorial assistance of:
Richard Toran, M.D.
Chief of Neurology
Newton-Wellesley Hospital
Assistant Professor of Neurology
Tufts School of Medicine
References
- Evans RW. Diagnostic testing for the evaluation of headaches.
Neurologic Clinics 1996; 14(1):1-26.
- American Academy of Neurology: Practice parameter: The electroencephalogram
in the evaluation of headache. Neurology 1995; 45:1411-1413.
- Dillon WP: Chapter 362. Neuroimaging in neurologic disorders.
In Fauci S, Braunwald E, Isselbacher KJ et al (eds): Harrisons
Principles of Internal Medicine. New York, McGraw-Hill, 1998,
p 2293.
- Gilman, S. Imaging the brain: first of two parts. NEJM 1998;
338(12):812-820.
For questions or comments about our diagnostic imaging educational
program or documents, please email web_comments@americanimaging.net
|